imipramine has been researched along with fluvoxamine in 100 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (16.00) | 18.7374 |
| 1990's | 34 (34.00) | 18.2507 |
| 2000's | 33 (33.00) | 29.6817 |
| 2010's | 16 (16.00) | 24.3611 |
| 2020's | 1 (1.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koe, BK; Kraska, AR; Sarges, R; Welch, WM | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Qin, W; Tian, S; Wold, EA; Xu, Q; Ye, N; Zhen, XC; Zhou, J | 1 |
| Brøsen, K; Skjelbo, E | 1 |
| Avenoso, A; Campo, GM; Caputi, AP; Pollicino, MA; Spina, E | 1 |
| Kapur, S; Mann, JJ | 1 |
| Kellett, JM | 1 |
| Broekkamp, CL; Jenck, F; Van Delft, AM | 1 |
| Bradshaw, CM; Shah, K; Szabadi, E | 1 |
| Greist, JH; Jefferson, JW; Kobak, KA; March, JS; Mazza, J | 1 |
| Baignoli, G; Ecari, U; Gonella, G | 1 |
| Azorin, JM; Bovier, P; Jeanningros, R; Tissot, R; Widmer, J | 1 |
| Ballenger, JC; Kellner, C; Laird, LK; Laraia, MT; Lydiard, RB; Morton, WA; Steele, TE | 1 |
| Boyer, WF; Feighner, JP; Hendrickson, GG; Meredith, CH | 1 |
| Asberg, M; Eriksson, B; Mårtensson, B; Träskman-Bendz, L; Wägner, A | 1 |
| Cassano, GB; Conti, L; Levine, J; Massimetti, G; Mengali, F; Waekelin, JS | 1 |
| Badoe, K; Browne, M; Horn, E; Lapierre, YD; Oyewumi, LK; Roberts, N; Sarantidis, D; Tessier, P | 1 |
| Wakelin, JS | 1 |
| Dreyfus, JF; Guelfi, JD; Pichot, P | 2 |
| Bovier, P; Gaillard, JM; Tissot, R; Widmer, J | 1 |
| Dominguez, RA; Goldstein, BJ; Jacobson, AF; Steinbook, RM | 1 |
| Bhat, AV; Norton, KR; Paykel, ES; Rao, B; Sireling, LI | 1 |
| Coleman, BS; Itil, TM; Michael, ST; Mukherjee, S; Shrivastava, RK | 1 |
| Ban, TA; Fjetland, OK; Guy, W; King, DL; Manov, G; Wilson, WH | 1 |
| Bradford, D; Krijzer, F; Snelder, M | 1 |
| Constantinidis, J; Dick, P; Tissot, R | 1 |
| Baba, T; Lee, JW; Shibuya, T; Takada, K; Takeda, H | 1 |
| Banki, CM | 1 |
| Ashford, JJ | 1 |
| Kasper, S; Möller, HJ; Montgomery, SA; Zondag, E | 1 |
| Brady, KT; Joffe, R; Kellner, CH; Laird, LK; Lydiard, RB; Morton, WA; Steele, TE | 1 |
| Jordan, S; Kramer, GL; Moeller, M; Petty, F; Zukas, PK | 1 |
| Avenoso, A; Campo, GM; Caputi, AP; Pollicino, AM; Spina, E | 1 |
| Ballenger, JC; Kellner, C; Laird, LK; Lydiard, RB; Morton, WA; Steele, TE; Thompson, NM | 1 |
| Avenoso, A; Campo, GM; Caputi, AP; Perucca, E; Pollicino, AM; Spina, E | 1 |
| Lam, RW; Maskall, DD | 1 |
| Brøsen, K; Loft, S; Poulsen, HE; Rasmussen, BB; Skjelbo, E | 1 |
| Brieaddy, L; Cooper, B; Ferris, RM; Hollingsworth, E; Mehta, N; Rigdon, G; Soroko, F; Wang, C; Wastila, W | 1 |
| Claghorn, JL; Earl, CQ; Houser, VP; Kanter, D; Stoner, KA; Walczak, DD; Wong, LF | 1 |
| Birkhimer, LJ; Fabre, L; Kapik, BM; Wong, LF; Zaborny, BA | 1 |
| Artigas, F; Bel, N | 1 |
| Brøsen, K | 1 |
| Artigas, F; Bel, N; Casanovas, JM; Romero, L | 1 |
| Bakish, D; Charbonneau, Y; Filteau, MJ; Fraser, G; Hooper, CL; Raine, D; Thibaudeau, C; West, DL | 1 |
| Amin, M; Bakish, D; Nair, NP; Saxena, B; Schwartz, G; West, TE | 1 |
| Bourin, M; Redrobe, JP | 1 |
| Ahern, D; Ball, SE; Kao, J; Scatina, J | 1 |
| Fundaró, A | 1 |
| Huang, SL; Xu, ZH; Zhou, HH | 1 |
| Meyers, BS | 1 |
| Ekstrom, RD; Golden, RN; Lydiard, RB; Mason, GA; Miller, HL | 1 |
| Iga, T; Odagiri, Y; Ohtani, H; Sato, H; Sawada, Y | 1 |
| Arisaka, O; Kano, K | 1 |
| Okuyama, S; Takamori, K; Yoshida, S | 2 |
| Broekman, TG; de Kemp, EC; Goedhart, A; Hoogduin, CA; Moleman, P; Schaap, CP; van den Berg, PC | 1 |
| Kwasucki, J; Maksymiuk, G; Olbrych-Karpińska, B; Stepień, A | 1 |
| Hashimoto, S; Hattori, T; Kawasaki, K; Kitamura, Y; Miki, N; Mochizuki, D; Otsuka, Y; Tsujita, R; Yamada, S | 1 |
| Bruijn, JA; Passchier, J; Pepplinkhuizen, L; Tulen, JH; Van Den Broek, WW; Volkers, AC | 1 |
| Gibert-Rahola, J; Gutiérrez, M; Micó, JA; Ortega-Alvaro, A | 1 |
| Bruyn, JA; Passchier, J; Pepplinkhuizen, L; Tulen, JH; van den Broek, WW; Volkers, AC | 1 |
| Birkenhäger, TK; Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW | 3 |
| Avissar, S; Matuzany-Ruban, A; Schreiber, G; Tzukert, K | 1 |
| Birkenhäger, TK; Bruijn, JA; Moleman, P; van den Broek, WW; Vulto, AG | 1 |
| Hayashi, T; Kumamaru, E; Kunugi, H; Numakawa, T; Su, TP; Yagasaki, Y | 1 |
| Higuchi, H; Sugawara, Y; Yoshida, K | 1 |
| Ishida, H; Iwata, M; Kawahara, R; Shirayama, Y | 1 |
| Bruijn, JA; Tulen, JH; van den Broek, WW; Volkers, AC | 1 |
| Brocco, M; Dekeyne, A; Millan, MJ; Papp, M | 1 |
| Aoki, M; Chiba, H; Harada, Y; Matsumiya, T; Nohara, J; Takeda, H; Tsuji, M | 1 |
| Daws, LC; Frosto-Burke, T; Hensler, JG; Munn, JL; Valdez, MF | 1 |
| Hazui, T; Hori, S; Matsuo, N; Miki, A; Nakano, M; Ohtani, H; Sawada, Y; Suzuki, Y; Yagi, H; Yamamoto, A | 1 |
| Birkenhäger, TK; Bruijn, JA; Fekkes, D; Moleman, P; Mulder, PG; van den Broek, WW | 1 |
| Hallifax, D; Houston, JB | 1 |
| Ikenouchi-Sugita, A; Nakamura, J; Yoshimura, R | 1 |
| Birkenhäger, TK; Heijnen, WT; Mulder, PG; van den Broek, WW | 1 |
| Ara, A; Banu, N; Zafir, A | 1 |
| Birkenhäger, TK; Mulder, PG; van den Broek, WW; Vermeiden, M | 1 |
| Bantsiele, GB; Bentué-Ferrer, D; Bourin, M; Laviolle, B; Reymann, JM; Saïkali, S | 1 |
| Aburakawa, Y; Aizawa, H; Hasebe, N; Kwak, S; Sawada, J; Yamashita, T | 1 |
| Balci, F; Campbell, U; Hanania, T; Olivier, BE; Paterson, NE | 1 |
| Birkenhäger, TK; Van Den Broek, WW | 1 |
| Hara, H; Hayashi, E; Kinoshita, M; Kuratani, K | 1 |
| Hara, H; Hayashi, E; Kinoshita, M; Kuratani, K; Shimamura, M | 1 |
| Preskorn, SH | 1 |
| Kasahara, J; Oka, N; Tezuka, K; Uchida, H | 1 |
| Matsumoto, M; Niwa, T; Shizuku, M; Yanai, M | 1 |
10 review(s) available for imipramine and fluvoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.
Topics: Allosteric Regulation; Clinical Trials as Topic; Humans; Ligands; Nervous System Diseases; Piperidines; Receptors, sigma; Sigma-1 Receptor; Small Molecule Libraries | 2020 |
The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy.
Topics: Antidepressive Agents; Depressive Disorder; Desipramine; Drug Therapy, Combination; Fluoxetine; Fluvoxamine; Humans; Imipramine; Mianserin; Suicide | 1991 |
Fluvoxamine: an antidepressant for the elderly?
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Dothiepin; Fluvoxamine; Humans; Imipramine; Mianserin; Middle Aged; Serotonin Antagonists | 1991 |
Therapeutic effects of serotonin uptake inhibitors in depression.
Topics: 5-Hydroxytryptophan; Alanine; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Imipramine; Oximes; Paroxetine; Piperidines; Propylamines; Serotonin; Serotonin Antagonists; Trazodone; Zimeldine | 1986 |
Fluvoxamine and tricyclic antidepressants (TCAs): how do the TCAs compare as "new" drugs with established fluvoxamine?
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Binding Sites; Cost-Benefit Analysis; Depressive Disorder; Fluvoxamine; Humans; Imipramine; Selective Serotonin Reuptake Inhibitors | 1995 |
Drug interactions and the cytochrome P450 system. The role of cytochrome P450 1A2.
Topics: Animals; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Fluvoxamine; Humans; Imipramine; Oxidoreductases; Selective Serotonin Reuptake Inhibitors | 1995 |
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
[Review of pharmacological efficacies and side effects of antidepressants].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Fluvoxamine; Humans; Imipramine; Maprotiline; Paroxetine; Sulpiride; Trazodone | 2007 |
Clinical psychopharmacology and medical malpractice: the four Ds.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Child; Depressive Disorder; Desipramine; Fatal Outcome; Female; Fluvoxamine; Forensic Psychiatry; Humans; Imipramine; Male; Malpractice; Mental Disorders; Psychopharmacology; Schizophrenia; Thioridazine | 2014 |
31 trial(s) available for imipramine and fluvoxamine
| Article | Year |
|---|---|
A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Fluvoxamine; Humans; Imipramine; Middle Aged; Oximes; Placebos | 1990 |
Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study.
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Oximes | 1990 |
Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Outpatients; Oximes; Random Allocation | 1989 |
A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Clinical Trials as Topic; Depression; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Oximes; Placebos; Psychiatric Status Rating Scales; Random Allocation | 1989 |
Use of a standardized documentation system (BLIPS/BDP) in the conduct of a multicenter international trial comparing fluvoxamine, imipramine, and placebo.
Topics: Adolescent; Adult; Aged; Child; Clinical Trials as Topic; Depressive Disorder; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Multi-Institutional Systems; Oximes; Research Design | 1986 |
Treatment of major affective disorder with fluvoxamine.
Topics: Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Oximes; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Random Allocation | 1987 |
Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.
Topics: Aged; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Oximes; Time Factors | 1986 |
Fluvoxamine and imipramine: results of a long-term controlled trial.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Long-Term Care; Male; Middle Aged; Oximes; Psychiatric Status Rating Scales | 1987 |
A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Nausea; Oximes; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Sleep Initiation and Maintenance Disorders; Vomiting; Xerostomia | 1985 |
A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients.
Topics: Adult; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Oximes; Psychological Tests | 1984 |
A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Electroencephalography; Female; Fluvoxamine; Hemodynamics; Humans; Imipramine; Male; Oximes; Psychiatric Status Rating Scales | 1983 |
A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.
Topics: Adult; Aged; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Electroencephalography; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Oximes; Psychiatric Status Rating Scales | 1983 |
A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
Topics: Adolescent; Adult; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Oximes; Random Allocation | 1984 |
Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 1995 |
A comparison of the effects of imipramine and fluvoxamine on the thyroid axis.
Topics: Adult; Analysis of Variance; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Thyroid Gland; Thyroid Hormones | 1994 |
Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients.
Topics: Adult; Aged; Blood Pressure; Cardiovascular Physiological Phenomena; Cardiovascular System; Depressive Disorder; Electrocardiography; Female; Fluvoxamine; Heart Rate; Humans; Hypotension, Orthostatic; Imipramine; Male; Middle Aged; Placebos; Pulse | 1993 |
Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Treatment Outcome | 1996 |
Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Constipation; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors | 1996 |
A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
Topics: Adult; Agoraphobia; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Panic Disorder; Psychiatric Status Rating Scales; Time Factors | 1996 |
Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1996 |
Noradrenergic function and clinical outcome in antidepressant pharmacotherapy.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Depression; Fluvoxamine; Humans; Imipramine; Melatonin; Norepinephrine; Pineal Gland; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
Diagnosis at the first episode to differentiate antidepressant treatment responses in patients with mood and anxiety disorders.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Diagnosis, Differential; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Mood Disorders; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2002 |
[Evaluation of analgesic action of fluvoxamine compared with efficacy of imipramine and tramadol for treatment of sciatica--open trial].
Topics: Adult; Aged; Analgesics, Opioid; Antidepressive Agents; Female; Fluvoxamine; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Sciatica; Tramadol; Treatment Outcome | 2002 |
Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
Topics: Adult; Affect; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Autonomic Nervous System; Blood Pressure; Depressive Disorder, Major; Double-Blind Method; Electrocardiography; Female; Fluvoxamine; Heart; Heart Rate; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Treatment Outcome | 2004 |
A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Inpatients; Male; Middle Aged; Patient Compliance; Patient Dropouts; Psychiatric Status Rating Scales; Treatment Outcome | 2004 |
Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluvoxamine; Hospitalization; Humans; Imipramine; Lithium; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2004 |
Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed?
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Male; Metabolic Clearance Rate; Mianserin; Middle Aged; Mirtazapine; Treatment Outcome | 2005 |
[Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition].
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Synergism; Female; Fluvoxamine; Humans; Imipramine; Lithium; Male; Middle Aged; Treatment Outcome | 2006 |
Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Pressure; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Female; Fluvoxamine; Humans; Hypotension, Orthostatic; Imipramine; Male; Middle Aged; Monoamine Oxidase Inhibitors; Phenelzine; Psychiatric Status Rating Scales; Tranylcypromine; Treatment Outcome | 2006 |
Prevalence of trait anxiety in a sample of depressed inpatients and its influence on response to antidepressants.
Topics: Adult; Aged; Antidepressive Agents; Anxiety; Depressive Disorder; Diazepam; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Inpatients; Male; Middle Aged; Netherlands; Predictive Value of Tests; Prevalence; Psychiatric Status Rating Scales; Severity of Illness Index; Time Factors; Treatment Outcome | 2010 |
Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients.
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Fluvoxamine; Humans; Imipramine; Inpatients; Linear Models; Male; Menopause; Middle Aged; Netherlands; Psychiatric Status Rating Scales; Sex Factors; Single-Blind Method; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2010 |
59 other study(ies) available for imipramine and fluvoxamine
| Article | Year |
|---|---|
Nontricyclic antidepressant agents derived from cis- and trans-1-amino-4-aryltetralins.
Topics: Animals; Antidepressive Agents; Dopamine; Isomerism; Male; Naphthalenes; Norepinephrine; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism; Synaptosomes; Tetrahydronaphthalenes; X-Ray Diffraction | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Inhibitors of imipramine metabolism by human liver microsomes.
Topics: Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Fluvoxamine; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Kinetics; Microsomes, Liver; Mixed Function Oxygenases; Polymorphism, Genetic; Quinidine; Selective Serotonin Reuptake Inhibitors | 1992 |
Interaction between fluvoxamine and imipramine/desipramine in four patients.
Topics: Depressive Disorder; Desipramine; Drug Interactions; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged | 1992 |
The effect of antidepressants on aversive periaqueductal gray stimulation in rats.
Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Biogenic Monoamines; Dopamine; Dose-Response Relationship, Drug; Electric Stimulation; Fluvoxamine; Imipramine; Male; Nomifensine; Norepinephrine; Oximes; Periaqueductal Gray; Rats; Rats, Inbred Strains; Reinforcement, Psychology; Serotonin; Sertraline | 1990 |
Interaction between antidepressants and d-amphetamine on variable-interval performance.
Topics: Animals; Antidepressive Agents; Desipramine; Dextroamphetamine; Dose-Response Relationship, Drug; Female; Fluvoxamine; Imipramine; Oximes; Psychomotor Performance; Rats; Rats, Inbred Strains; Reinforcement Schedule; Serotonin Antagonists; Trazodone | 1990 |
L-tyrosine and L-tryptophan membrane transport in erythrocytes and antidepressant drug choice.
Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Erythrocyte Membrane; Female; Fluvoxamine; Humans; Imipramine; Male; Mianserin; Middle Aged; Monoamine Oxidase Inhibitors; Oximes; Piperidines; Receptors, Adrenergic; Receptors, Serotonin; Tryptophan; Tyrosine | 1990 |
Evolution of red blood cell membrane transport and plasma level of L-tyrosine and L-tryptophan in depressed treated patients according to clinical improvement.
Topics: Adult; Aged; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Desipramine; Erythrocyte Membrane; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Oximes; Psychological Tests; Tryptophan; Tyrosine | 1988 |
Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model.
Topics: Amitriptyline; Animals; Antidepressive Agents; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Fluvoxamine; Imipramine; Male; Maprotiline; Mianserin; Oximes; Rats; Rats, Inbred Strains; Seizures; Viloxazine | 1984 |
Antidepressants and serotonin neurons of the raphe.
Topics: Animals; Antidepressive Agents, Tricyclic; Benzofurans; Brain Stem; Citalopram; Clomipramine; Ethers; Fluvoxamine; Imipramine; Indoles; Locus Coeruleus; Male; Microscopy, Fluorescence; Norepinephrine; Oximes; Piperidines; Propylamines; Raphe Nuclei; Rats; Receptors, Serotonin; Serotonin | 1981 |
[Effect of fluvoxamine, a new antidepressant drug, on monoamine dynamics in the rat cerebral limbic system and its pharmacological characteristic].
Topics: Administration, Oral; Amygdala; Animals; Biogenic Monoamines; Fluvoxamine; Hippocampus; Hydroxyindoleacetic Acid; Imipramine; Limbic System; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin | 1995 |
Prophylactic potential of selective reuptake inhibitors in suicidal patients.
Topics: Binding Sites; Depressive Disorder; Fluvoxamine; Frontal Lobe; Humans; Hydroxyindoleacetic Acid; Imipramine; Selective Serotonin Reuptake Inhibitors; Suicide; Suicide, Attempted | 1995 |
In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine.
Topics: Animals; Antidepressive Agents; Biogenic Monoamines; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Fluoxetine; Fluvoxamine; Imipramine; Male; Microdialysis; Norepinephrine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Serotonin | 1994 |
Fluvoxamine-induced alterations in plasma concentrations of imipramine and desipramine in depressed patients.
Topics: Adult; Depressive Disorder; Desipramine; Drug Interactions; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged | 1993 |
Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects.
Topics: Adult; Desipramine; Drug Interactions; Fluvoxamine; Humans; Imipramine; Male | 1993 |
Increased plasma concentration of imipramine following augmentation with fluvoxamine.
Topics: Adult; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Imipramine; Male; Parasympathetic Nervous System; Stimulation, Chemical | 1993 |
Fluvoxamine is a potent inhibitor of cytochrome P4501A2.
Topics: Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Fluvoxamine; Humans; Imipramine; Kinetics; Microsomes, Liver; Oxidoreductases, N-Demethylating; Phenacetin; Theophylline | 1993 |
Pharmacological properties of 403U76, a new chemical class of 5-hydroxytryptamine- and noradrenaline-reuptake inhibitor.
Topics: 5-Hydroxytryptophan; Adrenergic Uptake Inhibitors; Animals; Animals, Newborn; Benzyl Alcohols; Binding, Competitive; Dogs; Electrophysiology; Fluoxetine; Fluvoxamine; Hemodynamics; Imipramine; Male; Mice; Neurons; Norepinephrine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Species Specificity; Synaptic Transmission; Tetrabenazine; Vocalization, Animal | 1995 |
In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.
Topics: Adrenergic Uptake Inhibitors; Animals; Carrier Proteins; Cerebral Cortex; Citalopram; Clonidine; Desipramine; Fluoxetine; Fluvoxamine; Imipramine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Raphe Nuclei; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters | 1996 |
Adaptative changes of the serotonergic system after antidepressant treatments.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Clomipramine; Clorgyline; Fluvoxamine; Frontal Lobe; Hydroxyindoleacetic Acid; Imipramine; Microdialysis; Monoamine Oxidase Inhibitors; Piperidines; Pyrimidines; Raphe Nuclei; Rats; Serotonin; Stereotaxic Techniques; Tranylcypromine; Tryptophan | 1996 |
Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
Topics: Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Desipramine; Drug Interactions; Fluoxetine; Fluvoxamine; Imipramine; Ketanserin; Male; Maprotiline; Mice; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 1997 |
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride | 1997 |
Pinch-induced catalepsy in mice: a useful model to investigate antidepressant or anxiolytic drugs.
Topics: Amitriptyline; Animals; Anti-Anxiety Agents; Antidepressive Agents; Catalepsy; Female; Fluoxetine; Fluvoxamine; Imipramine; Learning; Male; Mice; Models, Psychological; Motor Activity; Ondansetron; Physical Stimulation; Reaction Time; Serotonin Antagonists; Sex Characteristics; Stereotyped Behavior | 1998 |
Inhibition of imipramine N-demethylation by fluvoxamine in Chinese young men.
Topics: Adult; Antidepressive Agents, Tricyclic; Area Under Curve; Desipramine; Drug Interactions; Fluvoxamine; Humans; Imipramine; Male; Selective Serotonin Reuptake Inhibitors | 1996 |
Milnacipran: new preparation. Tricyclics remain first-line antidepressants.
Topics: Amitriptyline; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Cyclopropanes; Drug Evaluation; Europe; Fluoxetine; Fluvoxamine; Humans; Imipramine; Meta-Analysis as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; United States | 1998 |
A comparative pharmacodynamic study of the arrhythmogenicity of antidepressants, fluvoxamine and imipramine, in guinea pigs.
Topics: Animals; Antidepressive Agents; Arrhythmias, Cardiac; Electrocardiography; Fluvoxamine; Guinea Pigs; Imipramine; Male | 2001 |
More on fluvoxamine and enuresis.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Case-Control Studies; Child; Cross-Over Studies; Deamino Arginine Vasopressin; Enuresis; Female; Fluvoxamine; Humans; Imipramine; Male; Renal Agents; Treatment Outcome | 2001 |
Availability of learned helplessness test as a model of depression compared to a forced swimming test in rats.
Topics: Amoxapine; Animals; Antidepressive Agents; Behavior, Animal; Clomipramine; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Fluvoxamine; Helplessness, Learned; Imipramine; Male; Mianserin; Motor Activity; Rats; Rats, Wistar; Swimming | 2001 |
Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Benzazepines; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Escape Reaction; Fluvoxamine; Helplessness, Learned; Imipramine; Male; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Sulpiride; Tetrahydronaphthalenes; Tranylcypromine | 2001 |
Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Behavior, Animal; Binding, Competitive; Brain Chemistry; Conditioning, Psychological; Cyclopropanes; Dose-Response Relationship, Drug; Fear; Fluoxetine; Fluvoxamine; Imipramine; Male; Maprotiline; Microdialysis; Milnacipran; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Prefrontal Cortex; Radioligand Assay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cell Surface; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming; Synaptosomes; Time Factors | 2002 |
24-Hour motor activity after treatment with imipramine or fluvoxamine in major depressive disorder.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Female; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Motor Activity; Time Factors | 2002 |
Interactions of acute morphine with chronic imipramine and fluvoxamine treatment on the antinociceptive effect in arthritic rats.
Topics: Analgesics; Animals; Arthritis, Experimental; Drug Interactions; Fluvoxamine; Imipramine; Male; Morphine; Pain Measurement; Rats; Rats, Wistar | 2003 |
Beta-arrestin-1 levels: reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain.
Topics: Adult; Aged; Animals; Antidepressive Agents; Arrestins; beta-Arrestin 1; beta-Arrestins; Brain Chemistry; Cerebral Cortex; Corpus Striatum; Depressive Disorder; Desipramine; Down-Regulation; Female; Fluvoxamine; Hippocampus; Humans; Imipramine; Leukocytes, Mononuclear; Male; Middle Aged; Psychiatric Status Rating Scales; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Severity of Illness Index | 2004 |
Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain-Derived Neurotrophic Factor; Calcium Channels; Fluvoxamine; Glutamic Acid; Imipramine; Inositol 1,4,5-Trisphosphate Receptors; Neurons; Neurotransmitter Agents; Rats; Receptors, Cytoplasmic and Nuclear; Receptors, sigma; Sigma-1 Receptor; Signal Transduction | 2006 |
Dramatic remission of treatment-resistant depression after the cessation of tricyclic antidepressants.
Topics: Adult; Antidepressive Agents, Tricyclic; Cabergoline; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Female; Fluvoxamine; Humans; Imipramine; Substance Withdrawal Syndrome; Treatment Outcome | 2006 |
Hippocampal synapsin I, growth-associated protein-43, and microtubule-associated protein-2 immunoreactivity in learned helplessness rats and antidepressant-treated rats.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Fluvoxamine; GAP-43 Protein; Helplessness, Learned; Hippocampus; Imipramine; Immunohistochemistry; Male; Microtubule-Associated Proteins; Rats; Rats, Sprague-Dawley; Reaction Time; Synapsins; Time Factors | 2006 |
Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
Topics: Aggression; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Behavior, Animal; Chronic Disease; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Fluvoxamine; Imipramine; Male; Mice; Motor Activity; Piribedil; Quinpirole; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Social Isolation; Stress, Psychological; Sucrose; Swimming | 2006 |
Antidepressants enhance the antinociceptive effects of carbamazepine in the acetic acid-induced writhing test in mice.
Topics: Acetic Acid; Analgesics, Non-Narcotic; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Carbamazepine; Cyclopropanes; Fluvoxamine; Imipramine; Male; Mice; Mice, Inbred ICR; Milnacipran; Pain; Pain Measurement | 2006 |
Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice.
Topics: Age Factors; Animals; Autoradiography; Brain-Derived Neurotrophic Factor; Dose-Response Relationship, Drug; Electrochemistry; Female; Fluvoxamine; Gene Expression; Hippocampus; Imipramine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Binding; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sex Factors | 2007 |
Piloerection induced by replacing fluvoxamine with milnacipran.
Topics: Adult; Antidepressive Agents; Cyclopropanes; Female; Fluvoxamine; Humans; Imipramine; Milnacipran; Models, Biological; Norepinephrine; Panic Disorder; Piloerection | 2007 |
Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antimanic Agents; Blood Platelets; Depressive Disorder; Drug Resistance; Female; Fluvoxamine; Humans; Hydroxyindoleacetic Acid; Imipramine; Lithium Compounds; Male; Middle Aged; Psychiatric Status Rating Scales; Serotonin | 2007 |
Saturable uptake of lipophilic amine drugs into isolated hepatocytes: mechanisms and consequences for quantitative clearance prediction.
Topics: Algorithms; Amines; Animals; Biological Transport; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Dextromethorphan; Fluoxetine; Fluvoxamine; Hepatocytes; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Imipramine; In Vitro Techniques; Kinetics; Male; Models, Biological; Propranolol; Quinine; Rats; Rats, Sprague-Dawley | 2007 |
Invivo antioxidant status: a putative target of antidepressant action.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antioxidants; Body Weight; Cyclohexanols; Depressive Disorder; Fluvoxamine; Food Preferences; Imipramine; Lipid Peroxidation; Protein Carbonylation; Rats; Restraint, Physical; Stress, Psychological; Swimming; Taste; Venlafaxine Hydrochloride | 2009 |
Behavioral effects of four antidepressants on an ischemic rat model of emotional disturbances.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety Disorders; Behavior, Animal; Brain Ischemia; Cyclopropanes; Depressive Disorder; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Fluvoxamine; Hippocampus; Imipramine; Immobility Response, Tonic; Male; Milnacipran; Motor Activity; Rats; Rats, Wistar | 2009 |
Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
Topics: Adenosine Deaminase; Amitriptyline; Amyotrophic Lateral Sclerosis; Antidepressive Agents; Arginine; Cyclopropanes; Desipramine; Fluoxetine; Fluvoxamine; Glutamine; HeLa Cells; Humans; Imipramine; Milnacipran; Morpholines; Paroxetine; Reboxetine; Receptors, AMPA; RNA Editing; RNA-Binding Proteins; RNA, Messenger | 2009 |
The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition.
Topics: Animals; Antidepressive Agents; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Desipramine; Diazepam; Dopamine Uptake Inhibitors; Fluvoxamine; Haloperidol; Imipramine; Male; Piperazines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology | 2011 |
Lithium addition to a tricyclic antidepressant results in optimal efficacy.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; Drug Resistance; Drug Synergism; Fluvoxamine; Humans; Imipramine; Lithium Compounds; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2011 |
Pharmacologically distinctive behaviors other than burying marbles during the marble burying test in mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Bupropion; Diazepam; Exploratory Behavior; Fluvoxamine; Imipramine; Male; Mice; Motor Activity | 2010 |
Automated experimental system capturing three behavioral components during murine forced swim test.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Bupropion; Desipramine; Equipment Design; Fluvoxamine; Image Interpretation, Computer-Assisted; Imipramine; Male; Mice; Mice, Inbred Strains; Pattern Recognition, Automated; Psychomotor Performance; Swimming; Video Recording | 2011 |
Postischemic Anhedonia Associated with Neurodegenerative Changes in the Hippocampal Dentate Gyrus of Rats.
Topics: Anhedonia; Animals; Antidepressive Agents; Brain Ischemia; Cell Proliferation; Dentate Gyrus; Disease Models, Animal; Fluvoxamine; Imipramine; Male; Nerve Degeneration; Neurons; Rats; Rats, Sprague-Dawley | 2016 |
Effect of Cytochrome P450 (CYP) 2D6 Genetic Polymorphism on the Inhibitory Action of Antidepressants on CYP2D6-Mediated Dopamine Formation from p-Tyramine.
Topics: Antidepressive Agents; Brain; Cytochrome P-450 CYP2D6; Desipramine; Dopamine; Dose-Response Relationship, Drug; Fluvoxamine; Humans; Imipramine; Polymorphism, Genetic; Structure-Activity Relationship; Tyramine | 2018 |